significant

New Study Reveals NatureKnit, a Patented, Natural Microbiome Ingredient, Exhibits a More Gentle and Significant Prebiotic Effect Compared with Purified FibersNew Study Reveals NatureKnit, a Patented, Natural Microbiome Ingredient, Exhibits a More Gentle and Significant Prebiotic Effect Compared with Purified Fibers

New Study Reveals NatureKnit, a Patented, Natural Microbiome Ingredient, Exhibits a More Gentle and Significant Prebiotic Effect Compared with Purified Fibers

MOMENCE, Ill., March 20, 2025 /PRNewswire/ -- New research published in Microorganisms has revealed the significant impact of NatureKnit™, an all-natural…

1 week ago
AirHelp Secures Significant Minority Investment from Abry PartnersAirHelp Secures Significant Minority Investment from Abry Partners

AirHelp Secures Significant Minority Investment from Abry Partners

BERLIN, March 18, 2025 /PRNewswire/ -- AirHelp Inc. ("AirHelp"), the global leader in air passenger rights and compensation claims management, is…

2 weeks ago
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury RecoveryExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery

ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery

TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…

2 weeks ago
Golden Gate Global Celebrates Significant Improvement in I-829 Petition Processing TimelinesGolden Gate Global Celebrates Significant Improvement in I-829 Petition Processing Timelines

Golden Gate Global Celebrates Significant Improvement in I-829 Petition Processing Timelines

SAN FRANCISCO, Feb. 20, 2025 /PRNewswire/ -- Golden Gate Global (GGG), a leading EB-5 regional center, is pleased to announce…

1 month ago
Apptronik Raises $350 Million to Scale Production of AI-Powered Humanoid Robots and Meet Significant Customer DemandApptronik Raises $350 Million to Scale Production of AI-Powered Humanoid Robots and Meet Significant Customer Demand

Apptronik Raises $350 Million to Scale Production of AI-Powered Humanoid Robots and Meet Significant Customer Demand

B Capital, Capital Factory and Google back Apptronik in the race to develop and deploy humanoid robots at scale February…

1 month ago
Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human GeneticsMyriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic…

3 months ago
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug NelonemdazGNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the…

4 months ago
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug NelonemdazGNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the…

4 months ago
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 MonthsOpen-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months

Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months

November 18, 2024 11:15 ET | Source: BridgeBio Pharma, Inc. - Acoramidis demonstrated the earliest known time to separation in…

4 months ago
Trump Wins the U.S. Election: Cryptocurrency Staking Market Primed for Significant Growth with STAKING AI at the HelmTrump Wins the U.S. Election: Cryptocurrency Staking Market Primed for Significant Growth with STAKING AI at the Helm

Trump Wins the U.S. Election: Cryptocurrency Staking Market Primed for Significant Growth with STAKING AI at the Helm

Los Angeles, CA, Nov. 08, 2024 (GLOBE NEWSWIRE) -- With the announcement of Donald Trump’s victory in the U.S. presidential…

5 months ago
Show more Posts